Together, these data show there is an upregulation of C/EBPα-K313 expression that may include regulation at both the translational and transcriptional levels and the enhanced and prolonged-expression of C/EBPα target gene expression in progenitor cells likely contributes to the leukaemia promoting effects of K313 mutations. The gene discussed is CEBPA; the disease is leukemia.